macrophag
import
natur
target
cell
previou
studi
viru
entri
cell
limit
involv
membran
cholesterol
lipid
raft
unknown
cholesterol
disrupt
macrophag
membran
use
four
pharmacolog
agent
act
differ
mechan
cyclodextrin
nystatin
filipin
complex
lovastatin
significantli
inhibit
product
hiv
entri
revers
transcript
inhibitori
effect
drug
result
decreas
viru
releas
infect
cell
could
substanti
revers
addit
watersolubl
cholesterol
viru
bound
equal
cholesteroldisrupt
cell
even
though
hiv
receptor
express
level
significantli
reduc
macrophag
found
partit
detergentresist
membran
typic
raftassoci
protein
hiv
particl
observ
colocalis
marker
lipid
raft
ctbfitc
earli
post
infect
data
suggest
macrophag
membran
cholesterol
essenti
hiv
entri
implic
lipid
raft
involv
viru
entri
target
cell
complex
process
involv
mani
cellular
viral
protein
primari
goal
overcom
barrier
cellular
membran
virus
achiev
acquir
lipid
envelop
exit
host
cell
envelop
virus
enter
cell
fusion
envelop
cellular
membran
either
cell
surfac
within
endosom
virus
without
lipid
envelop
acquir
mechan
penetr
membran
barrier
enter
cell
mainli
via
endocyt
pathway
use
either
clathrinco
vesicl
caveola
format
pore
cell
surfac
propos
polioviru
hogl
marsh
heleniu
smith
heleniu
grow
amount
evid
cholesterol
import
structur
compon
modul
fluiditi
biolog
membran
essenti
uptak
mani
virus
success
viru
entri
may
requir
cholesterol
host
cell
membran
viral
envelop
mani
envelop
virus
vaccinia
viru
chung
et
al
herp
simplex
viru
bender
et
al
sever
acut
respiratori
syndromecoronaviru
li
et
al
requir
cholesterol
target
cell
membran
true
mani
nonenvelop
virus
anderson
et
al
footandmous
diseas
viru
echoviru
marjomaki
et
al
pietiainen
et
al
requir
cholesterol
enter
cell
lipid
raftdepend
caveola
endocytosi
pathway
case
influenza
viru
presenc
cholesterol
viral
envelop
critic
essenti
target
cell
sun
whittak
wherea
convers
found
murin
leukaemia
viru
lu
silver
duck
hepat
b
viru
funk
et
al
contrast
variou
strain
dengu
viru
yellow
fever
viru
enter
infect
cell
independ
cholesterol
umashankar
et
al
cholesterol
concentr
within
fluid
mosaic
bilay
plasma
membran
along
sphingolipid
glycerophospholipid
specialis
dynam
microdomain
known
lipid
raft
lipid
assembl
tightli
packag
order
allow
float
within
rest
fluid
sea
disord
lipid
bilay
simon
ikonen
presenc
cholesterol
lipid
raft
confer
resist
deterg
low
temperatur
allow
separ
detergentsensit
membran
ultracentrifug
wilflingsed
stoiber
due
properti
often
refer
detergentresist
membran
drm
membran
raft
act
mobil
platform
within
plasma
membran
involv
mani
import
divers
cellular
process
mani
protein
associ
lipid
raft
includ
gpianchor
protein
gtpase
kinas
mount
evid
cholesterol
depend
product
viru
entri
suggest
mani
virus
may
hijack
dynam
lipid
raft
platform
utilis
entri
portal
cell
cholesterol
alreadi
known
import
multipl
stage
hiv
lifecycl
viru
assembl
bud
lipid
raft
domain
acquir
cholesterol
sphingomyelinrich
envelop
aloia
et
al
aloia
et
al
campbel
et
al
resist
deterg
strikingli
differ
composit
host
cell
membran
chan
et
al
hiv
accessori
protein
nef
function
mani
level
manipul
cellular
cholesterol
includ
bind
cholesterol
enhanc
traffick
virolog
raft
zheng
et
al
increas
cellular
cholesterol
biosynthesi
van
wout
et
al
inhibit
cholesterol
efflux
redistribut
major
compon
cholesterol
efflux
pathway
castrillo
et
al
although
contrast
studi
found
nef
specif
enhanc
incorpor
sphingomyelin
cholesterol
bud
viral
particl
brugger
et
al
import
hiv
envelop
lipid
composit
highlight
find
deplet
viral
envelop
cholesterol
caus
dramat
reduct
viral
infect
campbel
et
al
campbel
et
al
guyad
et
al
liao
et
al
earli
event
hiv
entri
viral
envelop
protein
engag
primari
receptor
target
cell
well
characteris
interact
permit
conform
chang
within
allow
addit
bind
coreceptor
usual
tlymphocyt
tropic
strain
macrophag
tropic
isol
coreceptor
bind
trigger
viru
entri
fusion
peptid
insert
cellular
membran
drive
fusion
event
lipid
composit
host
cell
import
hiv
entri
cholesterol
deplet
target
cell
use
pharmacolog
agent
prevent
hiv
entri
render
cell
resist
infect
kozak
et
al
liao
et
al
nguyen
taub
popik
et
al
associ
lipid
raft
domain
well
accept
kozak
et
al
nguyen
et
al
percheranci
et
al
popik
et
al
whether
associ
requir
support
product
viru
entri
disput
one
studi
found
mutant
target
nonraft
membran
permit
effici
hiv
entri
del
real
et
al
wherea
altern
mutant
also
prevent
associ
lipid
raft
found
support
hiv
entri
percheranci
et
al
popik
alc
membran
localis
coreceptor
molecul
somewhat
controversi
shown
associ
lipid
raft
microdomain
cell
line
presenc
drm
fraction
colocalis
raft
associ
lipid
mane
et
al
popik
et
al
contrast
studi
primari
cell
identifi
detergentsolubl
membran
dsm
fraction
repres
nonraft
membran
percheranci
et
al
report
lipid
raftassoci
cell
mane
et
al
nonraftassoci
cell
line
kozak
et
al
popik
et
al
bind
molecul
lipid
raft
propos
caus
recruit
hiv
coreceptor
lipid
raft
interfac
thu
bring
molecul
requir
hiv
entri
togeth
kozak
et
al
nguyen
et
al
popik
et
al
differ
product
entri
pathway
hiv
macrophag
describ
viru
taken
endocyt
rout
involv
macropinocytosi
constitut
process
wherebi
cell
take
larg
quantiti
extracellular
fluid
marech
et
al
numer
intracellular
pathogen
taken
macrophag
macropinocytosi
includ
brucella
watarai
et
al
afipia
feli
schneider
et
al
case
requir
lipid
raft
establish
cholesterol
alreadi
known
play
import
role
hiv
replic
macrophag
specif
studi
show
nef
affect
normal
function
atpbind
cassett
transport
impair
cholesterol
efflux
infect
macrophag
mujawar
et
al
modul
intracellular
lipid
metabol
hivinfect
macrophag
may
facilit
viru
bud
lipid
raft
associ
membran
tempt
infer
cholesterol
might
also
play
import
role
entri
hiv
macrophag
studi
regard
involv
cholesterol
lipid
raft
hiv
entri
perform
use
immortalis
cell
line
cell
line
primari
lymphocyt
given
critic
posit
hiv
pathogenesi
highli
special
cellular
architectur
thought
necessari
investig
requir
cholesterol
role
lipid
raft
entri
macrophag
assess
effect
deplet
cholesterol
macrophag
plasma
membran
use
four
differ
pharmacolog
agent
viru
bind
entri
hiv
receptor
level
show
membran
cholesterol
essenti
product
hiv
entri
macrophag
viru
bind
cholesteroldeplet
macrophag
reduc
alter
surfac
express
receptor
molecul
observ
viru
colocalis
marker
lipid
raft
earli
infect
isol
macrophag
membran
fraction
repres
raft
microdomain
togeth
sensit
viru
entri
membran
cholesterol
deplet
impli
role
macrophag
lipid
raft
entri
investig
involv
lipid
raft
hiv
uptak
macrophag
first
sought
visualis
viru
entri
lipid
raft
use
fluoresc
cholera
toxin
b
subunit
ctbfitc
bind
cluster
membran
domain
togeth
larger
patch
observ
microscop
hiv
pseudotyp
jrfl
envelop
bound
macrophag
ice
warm
presenc
ctbfitc
analys
variou
time
post
entri
repres
experi
taken
min
post
entri
shown
fig
show
viru
colocalis
ctbposit
area
macrophag
plasma
membran
number
particl
directli
associ
membran
cell
surfac
endocyt
vesicl
quantifi
take
zslice
cell
score
percentag
total
particl
colocalis
ctbfitc
three
consecut
zslice
focal
plane
shown
panel
ac
slice
start
toward
bottom
cell
proceed
upward
show
mani
cellassoci
viru
particl
clearli
colocalis
ctbfitc
distribut
viru
particl
ctbfitc
shown
project
zstack
slice
panel
analysi
multipl
cell
n
min
post
entri
show
approxim
sem
total
particl
colocalis
ctbfitc
later
time
post
entri
min
reduct
associ
viru
ctbfitc
perhap
due
product
entri
viru
particl
cytoplasm
degrad
viru
prevent
detect
fig
membran
cholesterol
disrupt
number
pharmacolog
agent
manipul
key
compon
lipid
microdomain
frequent
use
implic
assembl
viru
entri
effect
cyclodextrin
well
characteris
cholesterolbind
agent
incorpor
membran
select
extract
membran
cholesterol
bind
central
nonpolar
caviti
ilangumaran
hoessli
incub
macrophag
variou
concentr
serumfre
media
measur
deplet
lipid
raft
detect
fluoresc
ctbfitc
bind
raft
glycolipid
flow
cytometri
ctbfitc
bind
drugtreat
cell
ice
reduc
dosedepend
manner
compar
untreat
cell
confirm
effect
disrupt
macrophag
lipid
raft
fig
effect
drug
cell
viabil
measur
use
mt
cytotox
assay
fig
show
h
treatment
toxic
effect
macrophag
quantif
amount
free
cholesterol
cholesteryl
ester
mm
macrophag
use
amplex
red
cholesterol
quantif
assay
reveal
signific
decreas
p
pair
ttest
donor
test
averag
reduct
compar
untreat
control
cell
potenti
antivir
properti
hiv
entri
macrophag
test
measur
viru
revers
transcript
drugtreat
macrophag
hiv
envelop
acquir
cholesterol
bud
deplet
virion
cholesterol
result
reduc
viru
infect
guyad
et
al
liao
et
al
therefor
avoid
potenti
confound
effect
cell
pretreat
h
wash
extens
addit
viru
ensur
antivir
effect
observ
due
decreas
particl
infect
treatment
macrophag
found
significantli
reduc
gener
revers
transcript
product
follow
challeng
hiv
bal
concentr
test
macrophag
deriv
six
differ
donor
fig
inhibitori
effect
could
partial
revers
replenish
cellular
cholesterol
watersolubl
cholesterol
ad
h
directli
treatment
cholesterol
replenish
restor
viru
revers
transcript
untreat
control
fig
inhibitori
effect
also
observ
releas
infect
cell
measur
elisa
fig
reduc
releas
kinet
observ
earli
day
post
infect
donor
treat
effect
less
pronounc
due
longer
length
experi
measur
multipl
round
infect
restor
releas
kinet
observ
upon
cholesterol
replenish
therefor
deplet
macrophag
membran
cholesterol
sever
inhibit
earli
step
product
hiv
infect
macrophag
pinpoint
stage
cholesterolcontain
lipid
raft
requir
hiv
infect
determin
effect
cholesterol
deplet
viru
bind
macrophag
equal
amount
hiv
bal
ad
untreat
macrophag
h
ice
unbound
virion
remov
extens
wash
cell
lyse
amount
cellassoci
viru
determin
elisa
fig
slight
decreas
viru
adsorpt
macrophag
compar
untreat
control
cell
observ
howev
decreas
signific
would
account
decreas
observ
revers
transcript
cell
therefor
cholesterol
lipid
raft
might
play
minor
role
viru
bind
like
requir
entri
postentri
event
decreas
entri
hiv
might
attribut
alter
receptor
coreceptor
level
therefor
sought
determin
treatment
macrophag
alter
level
detect
cell
surfac
molecul
use
antibodi
label
follow
flow
cytometri
show
control
macrophag
express
detect
level
fig
treatment
macrophag
significantli
decreas
cell
surfac
express
receptor
express
level
restor
upon
cholesterol
replenish
impli
decreas
due
sole
cholesterol
deplet
interestingli
replenish
cholesterol
restor
express
level
reduc
almost
undetect
level
reduct
express
may
explain
cholesterol
replenish
partial
restor
hiv
revers
transcript
see
treatment
macrophag
reduc
express
membran
protein
express
transferrin
receptor
known
nonraft
associ
protein
reduc
therefor
select
alter
exposur
protein
found
cholesterolrich
lipid
raft
membran
without
effect
nonraft
associ
protein
combin
decreas
receptor
level
may
account
decreas
product
hiv
entri
reduct
hiv
receptor
level
cholesteroldeplet
macrophag
colocalis
viru
marker
lipid
raft
may
impli
receptor
localis
microdomain
tradit
method
isol
lipid
raft
reli
cholesterol
properti
favour
format
membran
resist
deterg
low
temperatur
separ
solubl
membran
ultracentrifug
adapt
procedur
isol
macrophag
drm
disrupt
cell
combin
nitrogen
cavit
homogenis
follow
fraction
use
optiprep
densiti
gradient
western
blot
analysi
equal
volum
fraction
show
expect
localis
control
protein
locat
fraction
repres
drm
transferrin
receptor
fraction
indic
dsm
fig
receptor
present
detergentresist
fraction
similar
distribut
although
also
present
low
level
fraction
present
detergentresist
fraction
therefor
receptor
requir
macrophagetrop
hiv
entri
resid
drm
fraction
macrophag
membran
properti
lipid
raft
contain
raftassoci
protein
macrophag
h
ice
measur
determin
amount
cellassoci
viru
use
elisa
data
repres
mean
sd
result
obtain
multipl
independ
experi
use
sever
donor
donor
ctb
viabil
hiv
bind
assay
donor
qpcr
data
repres
donor
signific
differ
p
b
extrem
signific
differ
p
b
pair
ttest
exclud
drugspecif
effect
use
two
compound
bind
cholesterol
disrupt
lipid
raft
directli
insert
membran
sequest
cholesterol
complex
nystatin
filipin
complex
concentr
significantli
inhibit
ctbfitc
bind
fig
compromis
cell
viabil
fig
inhibit
hiv
infect
dosedepend
manner
nystatin
concentr
significantli
reduc
revers
transcript
infect
cell
respect
compar
treat
concentr
dmso
vehicl
fig
filipin
complex
significantli
inhibit
number
hiv
revers
transcript
compar
untreat
control
fig
similarli
inhibitori
effect
observ
reduc
releas
kinet
earli
time
point
post
infect
fig
nystatin
filipin
complex
reduc
viru
bind
macrophag
fig
support
find
obtain
treatment
impli
cholesterol
lipid
raft
like
requir
entri
andor
postentri
event
bind
studi
indic
hiv
receptor
sensit
cholesterol
deplet
sought
determin
receptor
level
would
also
alter
cholesterol
organis
disrupt
anoth
mechan
fig
nystatin
significantli
decreas
express
respect
express
level
slightli
decreas
howev
nystatin
significantli
reduc
level
indic
drug
might
reduc
cell
surfac
express
mani
protein
includ
outsid
lipid
raft
convers
filipin
complex
margin
decreas
effect
level
antivir
effect
nystatin
might
explain
lower
level
like
filipin
complex
might
inhibit
infect
differ
mechan
decreas
receptor
level
cholesterolbind
drug
nystatin
filipin
mechan
disrupt
lipid
raft
either
activ
remov
sequest
cholesterol
lipid
raft
also
disrupt
use
statin
lovastatin
drug
inhibit
coenzym
hmgcoa
reductas
enzym
respons
product
mevalon
precursor
cholesterol
biosynthesi
cell
treat
lovastatin
day
presenc
serumfre
medium
supplement
lipoproteindefici
serum
cell
viabil
unaffect
fig
bind
ctbfitc
lovastatintr
cell
reduc
compar
untreat
cell
fig
lovastatin
treatment
macrophag
significantli
inhibit
hiv
revers
transcript
dosedepend
manner
lovastatin
respect
fig
mark
decreas
surfac
express
hiv
receptor
nystatin
filipin
complex
treatment
determin
stain
macrophag
fluoresc
antibodi
appropri
isotyp
control
cell
surfac
bind
measur
flow
cytometri
mean
fluoresc
intens
valu
calcul
subtract
isotyp
control
fluoresc
specif
antibodi
fluoresc
data
repres
mean
sd
result
obtain
multipl
independ
experi
donor
qpcr
ctb
bind
assay
donor
receptor
express
viabil
data
repres
least
donor
signific
differ
p
b
signific
differ
p
b
pair
ttest
releas
kinet
compar
untreat
control
also
observ
fig
effect
lovastatin
hiv
revers
transcript
partial
revers
addit
mevalon
product
hmgcoa
reductas
cultur
medium
fig
surfac
express
level
hiv
receptor
decreas
lovastatin
treatment
signific
level
fig
although
effect
consist
implic
normal
cholesterol
synthesi
product
viru
entri
receptor
express
level
unabl
detect
signific
chang
cholesterol
abund
per
se
lovastatintr
cell
use
standard
assay
demonstr
critic
import
cholesterol
entri
macrophag
firstli
show
product
viru
entri
significantli
reduc
macrophag
target
cell
treat
cholesteroldeplet
drug
incub
cell
drug
addit
viru
cholesterol
target
cell
would
remov
allow
viru
particl
cholesterol
infect
remain
intact
addit
exogen
cholesterol
macrophag
membran
directli
macrophag
pretreat
lovastatin
andor
mevalon
whose
product
block
lovastatin
day
product
hiv
entri
measur
qpcr
detect
hiv
bal
revers
transcript
h
infect
f
surfac
express
hiv
receptor
lovastatin
treatment
determin
stain
macrophag
fluoresc
antibodi
appropri
isotyp
control
data
repres
mean
sd
result
obtain
multipl
independ
experi
donor
ctb
viabil
assay
donor
qpcr
donor
receptor
express
data
repres
donor
extrem
signific
differ
p
b
pair
ttest
treatment
substanti
restor
hiv
infect
indic
decreas
infect
least
part
due
deplet
cholesterol
cell
membran
secondli
modifi
properti
cholesterolrich
macrophag
membran
use
nystatin
filipin
complex
sequest
cholesterol
larg
aggreg
treatment
macrophag
drug
significantli
inhibit
product
hiv
entri
concentrationdepend
manner
thirdli
deplet
macrophag
cholesterol
use
lovastatin
compound
inhibit
hmgcoa
reductas
rate
limit
enzym
cholesterol
biosynthesi
significantli
inhibit
hiv
product
entri
prolong
day
treatment
incub
macrophag
mevalon
whose
product
prevent
lovastatin
partial
restor
product
hiv
entri
macrophag
therefor
modif
macrophag
membran
cholesterol
content
use
differ
pharmacolog
inhibitor
act
cholesterol
differ
mechan
significantli
inhibit
hiv
entri
cholesterol
major
compon
lipid
raft
microdomain
manipul
localis
presenc
within
membran
frequent
use
implic
lipid
assembl
viru
entri
provid
addit
evid
involv
macrophag
lipid
raft
microdomain
entri
observ
viru
colocalis
marker
ctbfitc
microdomain
earli
time
postinfect
furthermor
isol
receptor
molecul
receptor
typic
utilis
macrophagetrop
virus
drm
fraction
partit
knownraft
associ
protein
result
confirm
observ
regard
import
target
cell
plasma
membran
cholesterol
lipid
raft
microdomain
viru
entri
cell
line
primari
cell
liao
et
al
mane
et
al
percheranci
et
al
popik
et
al
extend
macrophag
critic
natur
target
cell
virus
infect
target
cell
firstli
bind
attach
factor
receptor
molecul
cell
surfac
decreas
product
viru
entri
may
reflect
reduct
viru
bind
cell
confirm
stage
infect
affect
cholesterol
deplet
investig
viru
bind
macrophag
membran
signific
decreas
amount
bound
viru
h
incub
ice
observ
drugtreat
control
untreat
macrophag
indic
cholesterol
deplet
macrophag
perturb
attach
viru
perhap
altern
molecul
heparan
sulphat
glycosaminoglycan
saphir
et
al
must
alter
viru
entri
event
attach
surfac
express
level
hiv
receptor
found
alter
differ
extent
pharmacolog
agent
treatment
pronounc
effect
receptor
significantli
reduc
surfac
level
disappear
almost
undetect
level
cholesterol
replenish
restor
level
similar
level
untreat
macrophag
interestingli
express
decreas
cholesterol
replenish
almost
undetect
level
complet
knockdown
surfac
express
may
explain
partial
restor
hiv
revers
transcript
observ
upon
cholesterol
replenish
treatment
macrophag
addit
cholesterol
may
reduc
express
level
favour
hiv
infect
mechan
cholesterol
decreas
surfac
express
unknown
cholesteroltr
macrophag
granular
appear
flow
cytometri
specul
macrophag
activ
take
cholesterol
via
endocyt
mechan
may
simultan
internalis
uncommon
cholesterol
replenish
give
rise
partial
restor
infect
report
virus
suggest
explan
one
form
cholesterol
may
restor
tang
et
al
reduct
surfac
express
hiv
receptor
follow
deplet
membran
cholesterol
contrast
find
use
differ
cell
treatment
similar
concentr
caus
reduct
plasma
membran
express
primari
tcell
percheranci
et
al
pbl
viard
et
al
cell
line
reduct
surfac
express
upon
cholesterol
treatment
best
knowledg
seem
uniqu
macrophag
observ
may
result
differ
express
internalis
macrophag
compar
lymphocyt
macrophag
express
level
lower
cell
collman
et
al
kazazi
et
al
lee
et
al
internalis
rate
enhanc
like
due
absenc
lck
pelchenmatthew
et
al
reduct
surfac
express
report
treatment
cyclodextrin
deriv
bcd
primari
cell
liao
et
al
importantli
cholesterol
shown
essenti
conform
integr
studi
bcd
treatment
prevent
cell
surfac
bind
antibodi
specif
distinct
epitop
taub
molecular
simul
work
model
membran
defin
composit
show
integr
lipid
raft
microdomain
sensit
minor
chang
overal
cholesterol
concentr
risselada
marrink
like
cholesterol
deplet
macrophag
disrupt
lipid
raft
therebi
redistribut
raftassoci
protein
membran
domain
possibl
new
context
conform
alter
one
longer
recognis
antibodi
unabl
sustain
hiv
entri
nystatin
filipin
complex
modifi
cholesterol
organis
within
cell
affect
overal
cholesterol
concentr
differ
effect
hiv
receptor
level
nystatin
significantli
decreas
surfac
express
also
significantli
decreas
nonraft
associ
impli
effect
nystatin
may
restrict
protein
locat
cholesterol
rich
domain
convers
filipin
complex
treatment
significantli
reduc
express
level
slightli
decreas
level
appear
dramat
effect
express
membran
protein
effect
cholesterol
sequester
surfac
express
hiv
receptor
nystatin
filipin
treatment
investig
disrupt
cholesterol
biosynthesi
lovastatin
also
reduc
surfac
express
hiv
receptor
macrophag
signific
level
contrast
observ
lymphocyt
lovastatin
downmodul
mrna
cell
surfac
protein
express
result
reduc
infect
nabatov
et
al
sensit
viru
entri
deplet
cellular
cholesterol
could
explain
associ
viral
receptor
lipid
raft
tightli
structur
cholesterolrich
lipid
raft
known
drm
isol
presenc
ice
cold
triton
separ
ultracentrifug
macrophag
found
drm
fraction
along
whose
locat
membran
well
known
contrast
found
solubl
fraction
reflect
associ
nonraft
membran
decreas
hiv
receptor
express
treatment
support
notion
hiv
receptor
locat
cholesterolrich
domain
macrophag
provid
addit
evid
involv
lipid
raft
viru
entri
visualis
viru
uptak
parallel
fluoresc
marker
lipid
raft
min
post
infect
approxim
third
cellassoci
virion
colocalis
lipid
raft
membran
punctat
structur
appear
internalis
may
resembl
endosom
compart
associ
drm
establish
mani
differ
cell
type
show
true
macrophag
kozak
et
al
liao
et
al
nguyen
et
al
percheranci
et
al
popik
et
al
report
present
lipid
raft
cell
line
artifici
overexpress
receptor
mane
et
al
popik
et
al
primari
lymphocyt
receptor
found
nonraft
membran
domain
percheranci
et
al
show
macrophag
also
present
associ
lipid
raft
receptor
requir
macrophagetrop
viru
entri
localis
similar
membran
domain
agreement
electron
micrograph
show
localis
outer
membran
microvilli
bleb
macrophag
often
close
appos
microdomain
singer
et
al
howev
despit
exist
togeth
drm
possibl
aggreg
receptor
still
requir
may
occur
upon
bind
like
explan
inhibit
product
hiv
entri
cholesteroldeplet
macrophag
redistribut
conform
chang
hiv
receptor
render
macrophag
unsuscept
hiv
infect
plausibl
manipul
membran
cholesterol
may
inhibit
entri
mechan
suggest
five
possibl
deplet
macrophag
cholesterol
may
alter
lipid
composit
cellular
plasma
membran
longer
compet
fusion
hiv
lipid
envelop
disrupt
membran
raft
may
prevent
receptor
migrat
colocalis
mobil
within
cellular
membran
shown
cho
cell
chemokin
receptor
significantli
mobil
requir
membran
cholesterol
mobil
steffen
hope
signal
transduct
pathway
induc
upon
envelop
engag
may
requir
viru
entri
harmon
ratner
cholesterol
shown
essenti
signal
deplet
may
prevent
import
signal
event
macrophag
cardaba
et
al
hiv
entri
macrophag
may
proceed
macropinocytosi
cholesteroldeplet
may
block
uptak
pathway
macrophag
report
brain
microvascular
endothelia
liu
et
al
lovastatin
may
inhibit
hiv
entri
anoth
mechan
shown
blockad
hmg
coa
reductas
imped
prenyl
small
rho
gtpase
may
involv
postentri
signal
event
del
real
et
al
diminish
attach
target
cell
suppress
interact
giguer
tremblay
howev
address
possibl
determin
exact
role
cholesterol
challeng
especi
use
infecti
macrophagetrop
viru
primari
macrophag
studi
highlight
import
cholesterol
lipid
raft
macrophag
hiv
infect
provid
support
use
cholesterol
lower
pharmacolog
agent
antiretrovir
therapi
confirm
antivir
effect
anoth
pathogen
signific
hiv
target
cell
macrophag
peripher
blood
mononuclear
cell
pbmc
isol
use
ficollpaqu
plu
ge
healthcar
densiti
gradient
centrifug
blood
healthi
donor
monocyt
isol
posit
select
use
magnet
bead
miltenyi
biotec
accord
manufactur
instruct
monocyt
seed
densiti
cellscm
plate
plate
plate
flask
cultur
media
refer
rpmi
fc
mcsf
consist
rpmi
paa
fetal
calf
serum
fc
paa
mm
lglutamin
paa
uml
penicillin
streptomycin
paa
supplement
ngml
approxim
uml
recombin
human
mcsf
r
system
monocyt
differenti
day
prior
use
bal
obtain
aid
research
refer
reagent
program
divis
aid
niaid
nih
gartner
gartner
et
al
viral
stock
gener
differenti
unstimul
pbmc
infect
cell
supernat
harvest
day
infect
frozen
use
infect
assay
viru
stock
provir
dna
remov
gener
qpcr
experi
treatment
dnase
sigma
gener
singl
round
replic
compet
viru
cell
regularli
passag
dmem
paa
fc
mm
lglutamin
uml
penicillin
streptomycin
cell
seed
flask
transfect
pjrfl
env
use
fugen
accord
manufactur
instruct
jrfl
viru
harvest
h
later
pass
filter
frozen
macrophag
wash
serumfre
rpmi
treat
h
vari
concentr
filipin
complex
nystatin
sigma
dilut
serumfre
rpmi
nystatin
dissolv
dmso
filipin
water
exclud
effect
solvent
control
cell
incub
dilut
dmso
use
nystatin
incub
cell
wash
serumfre
rpmi
prior
infect
flow
cytometri
analysi
follow
infect
cell
cultur
rpmi
fc
mcsf
water
solubl
cholesterol
sigma
ad
h
state
lovastatin
treatment
macrophag
wash
serumfre
rpmi
addit
vari
concentr
lovastatin
sigma
without
mevalon
sigma
dilut
rpmi
lipoproteindefici
serum
sigma
cell
left
day
infect
flow
cytometri
analysi
infect
cell
cultur
rpmi
fc
mcsf
follow
infect
procedur
determin
cell
viabil
follow
treatment
cholesterol
disrupt
agent
macrophag
incub
celltit
aqueou
one
solut
cell
prolifer
assay
reagent
promega
dilut
serumfre
rpmi
rpmi
lipoproteindefici
serum
contain
lovastatin
mevalon
h
triplic
sampl
supernat
transfer
well
plate
absorb
read
nm
background
absorb
read
reagent
media
alon
deduct
valu
express
percentag
untreat
cell
quantifi
cellular
cholesterol
level
drug
treat
control
macrophag
detach
pipet
pb
contain
mm
edta
mm
lidocain
sigma
ice
cell
lyse
cholesterol
extract
previous
describ
chung
et
al
amount
cholesterol
assay
amplex
red
cholesterol
assay
kit
molecular
probe
accord
manufactur
instruct
concentr
determin
standard
curv
normalis
number
cell
macrophag
infect
plate
dnase
treat
bal
spinocul
seal
plate
spin
centrifug
min
viru
inoculum
remov
cell
overlaid
rpmi
fc
mcsf
infect
left
proceed
h
cell
harvest
scrape
dna
extract
use
dneasi
blood
tissu
kit
qiagen
accord
manufactur
instruct
qpcr
reaction
detect
late
stage
revers
transcript
product
carri
previous
describ
butler
et
al
cohen
et
al
standard
consist
e
backbon
plasmid
dilut
hela
dna
use
duplic
dilut
rang
copi
actin
standard
consist
human
xsomal
dna
eurogentec
use
dilut
ng
measur
multipl
round
hiv
infect
macrophag
infect
plate
bal
h
inoculum
remov
replac
rpmi
fc
mcsf
day
period
supernat
sampl
taken
interv
kept
analysi
bind
macrophag
incub
hiv
bal
h
ice
cell
wash
time
icecold
pb
remov
unbound
viru
lyse
te
tri
buffer
salin
tb
empigen
fluka
fc
tween
heat
inactiv
analysi
product
sampl
infect
cell
dilut
te
heat
inactiv
creat
standard
curv
recombin
protein
aalto
dilut
doubl
dilut
te
costar
eiaria
flat
bottom
high
bind
plate
corn
precoat
sheep
gag
antibodi
clone
aalto
dilut
carbonatebicarbon
buffer
ph
sigma
block
bsa
sigma
te
dilut
sampl
standard
ad
plate
overnight
incub
room
temperatur
bound
detect
use
biotinyl
mous
gag
antibodi
clone
centr
aid
reagent
nibsc
ttss
tb
fc
tween
follow
streptavidinhrp
pierc
plate
develop
use
tmb
substrat
pierc
reaction
stop
h
sigma
plate
read
use
molecular
devic
e
max
precis
micropl
reader
softmax
pro
softwar
version
graphpad
prism
softwar
version
use
creat
standard
curv
bind
equat
calcul
unknown
valu
detach
macrophag
wash
fac
buffer
pb
nan
fc
human
igg
cell
incub
directli
conjug
mous
antihuman
antibodi
clone
clone
clone
appropri
isotyp
control
r
system
control
express
nonraft
associ
protein
transferrin
receptor
also
measur
use
mous
antihuman
clone
isotyp
control
mous
clone
dilut
immunotool
cell
fix
formaldehyd
flow
cytometri
carri
use
bectondickinson
facscalibur
flow
cytomet
event
collect
data
analys
use
flowjo
softwar
version
macrophag
wash
serumfre
rpmi
incub
ctbfitc
sigma
serumfre
rpmi
min
ice
detach
cell
analys
flow
cytometri
describ
visualis
viru
ctb
capabl
singl
round
infect
jrfl
spinocul
h
onto
day
macrophag
monolay
seed
onto
glass
coverslip
well
plate
cell
wash
icecold
pb
incub
rpmi
contain
ctbfitc
min
cell
fix
formaldehyd
quench
mm
glycin
pb
permeabilis
buffer
contain
fc
saponin
human
igg
pb
detect
viru
cell
stain
mous
antihiv
dilut
clone
centr
aid
reagent
nibsc
follow
alexa
fluor
conjug
goat
antimous
antibodi
dilut
clone
invitrogen
coverslip
mount
slide
use
mowiol
imag
collect
use
zeiss
pascal
microscop
macrophag
harvest
scrape
pellet
suspend
ml
h
buffer
mm
sodium
hepe
ph
mm
sucros
mm
mgcl
mm
naf
mm
vanad
contain
proteas
inhibitor
roch
cell
nitrogencavit
use
nitrogen
cavit
bomb
model
parr
instrument
compani
equilibr
bar
min
harder
kuhn
cell
disrupt
ad
ml
hne
buffer
mm
hepe
ph
mm
nacl
mm
edta
passag
time
syring
triton
ad
cell
incub
h
extract
contain
approxim
cell
adjust
nycom
pharma
transfer
centrifug
tube
beckman
coulter
overlaid
anoth
optiprep
make
ml
layer
overlaid
ml
optiprep
hne
gradient
spun
rpm
h
nine
fraction
collect
precipit
equal
vol
trichloroacet
acid
wash
twice
icecold
aceton
resuspend
urea
sd
sampl
buffer
equal
volum
fraction
run
sdspage
protein
gel
biorad
precis
plu
protein
standard
protein
transfer
onto
pvdf
membran
membran
incub
primari
mous
antihuman
antibodi
clone
r
system
clone
r
system
clone
bd
bioscienc
transferrin
receptor
clone
bd
bioscienc
detect
primari
antibodi
bind
membran
incub
goat
antimous
igg
fab
specif
antibodi
conjug
alkalin
phosphatas
sigma
dilut
protein
detect
use
ecf
substrat
pierc
membran
imag
use
storm
imag
statist
analysi
perform
twotail
pair
ttest
unpair
replic
use
graphpad
prism
version
star
indic
p
valu
signific
p
signific
p
extrem
signific
p
b
